Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 third quarter ended March 31, 2025. Fiscal-year 202...
CHARLOTTE, N.C.: Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 third quarter ended March 31, 2025.
Fiscal-year 2025 third quarter total net revenue of $261.4 million decreased 9% from the prior-year period, but increased 9% from the fiscal-year 2025 second quarter. Net income from continuing operations was $27.6 million, or $0.32 per share, compared to a net loss from continuing operations of $48.9 million, or a loss of $0.36 per share, in the prior-year period. Adjusted EBITDA* of $71.7 million decreased 25% from the prior-year period, but increased 43% from the fiscal-year 2025 second quarter. Adjusted EPS* of $0.44 decreased 10% from the prior-year period, but increased 76% from the fiscal-year 2025 second quarter.
"Our overall revenue and profitability grew sequentially and exceeded our expectations for the third quarter largely due to better-than-anticipated results in our Supply Chain Services segment," said Michael J. Alkire, Premier's President and CEO. "As a result, we are increasing our adjusted EBITDA and adjusted EPS guidance and reaffirming the midpoint of our consolidated revenue guidance range. In addition, adjusted EPS also benefited from share repurchases under our $1 billion share repurchase authorization, including the initiation of a $200 million accelerated share repurchase program announced in February as we continue to return capital to stockholders."
On October 1, 2024, the company announced that it had divested the S2S Global direct sourcing business. As such, and unless stated otherwise, all results presented in the following release reflect those of continuing operations. In addition, as the company's efforts to transfer to partners or wind down certain components of the Contigo Health business remain ongoing, results presented in this release continue to include contributions from that business. However, because of the expected transition and/or wind-down, the company is providing certain financial measures that exclude contributions from this business, and tables are included at the end of this release that reconcile the impact of the Contigo Health business on certain financial measures in the periods presented.
Consolidated Financial Highlights of Continuing Operations |
|
|
|
| |||||||||||||
| Three Months Ended March 31, |
| Nine Months Ended March 31, | ||||||||||||||
(in thousands, except per share data) |
| 2025 |
|
| 2024 |
| % Change |
|
| 2025 |
|
| 2024 |
| % Change | ||
Net revenue: |
|
|
|
|
|
|
| ||||||||||
Supply Chain Services: |
|
|
|
|
|
|
| ||||||||||
Net administrative fees | $ | 142,234 |
| $ | 157,666 |
| (10 | %) |
| $ | 406,276 |
| $ | 458,022 |
| (11 | %) |
Software licenses, other services, and support |
| 18,671 |
|
| 17,796 |
| 5 | % |
|
| 54,763 |
|
| 46,938 |
| 17 | % |
Total Supply Chain Services |
| 160,905 |
|
| 175,462 |
| (8 | %) |
|
| 461,039 |
|
| 504,960 |
| (9 | %) |
Performance Services |
| 100,477 |
|
| 111,404 |
| (10 | %) |
|
| 288,751 |
|
| 330,803 |
| (13 | %) |
Performance Services excluding Contigo Health |
| 94,359 |
|
| 100,927 |
| (7 | %) |
|
| 266,942 |
|
| 299,542 |
| (11 | %) |
Net revenue | $ | 261,382 |
| $ | 286,866 |
| (9 | %) |
| $ | 749,790 |
| $ | 835,763 |
| (10 | %) |
Net revenue excluding Contigo Health* | $ | 255,264 |
| $ | 276,389 |
| (8 | %) |
| $ | 727,981 |
| $ | 804,502 |
| (10 | %) |
|
|
|
|
|
|
|
| ||||||||||
Net income (loss) from continuing operations | $ | 27,613 |
| $ | (48,859 | ) | NM |
|
| $ | 54,716 |
| $ | 43,358 |
| 26 | % |
Net income (loss) from continuing operations attributable to stockholders | $ | 27,839 |
| $ | (39,892 | ) | NM |
|
| $ | 43,598 |
| $ | 56,112 |
| (22 | %) |
|
|
|
|
|
|
|
| ||||||||||
Diluted earnings (loss) per share from continuing operations attributable to stockholders | $ | 0.32 | $ | (0.36 | ) | NM |
|
| $ | 0.46 | $ | 0.48 | (4 | %) | |||
NM = not meaningful |
Consolidated Non-GAAP Financial Highlights of Continuing Operations |
|
|
|
| |||||||||||||
| Three Months Ended March 31, |
| Nine Months Ended March 31, | ||||||||||||||
(in thousands, except per share data) |
| 2025 |
|
| 2024 |
| % Change |
|
| 2025 |
|
| 2024 |
| % Change | ||
|
|
|
|
|
|
|
| ||||||||||
NON-GAAP FINANCIAL MEASURES*: |
|
|
|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
| ||||||||||
Adjusted EBITDA: |
|
|
|
|
|
|
| ||||||||||
Supply Chain Services | $ | 85,665 |
| $ | 102,133 |
| (16 | %) |
| $ | 236,916 |
| $ | 300,052 |
| (21 | %) |
Performance Services |
| 19,450 |
|
| 26,890 |
| (28 | %) |
|
| 43,522 |
|
| 81,025 |
| (46 | %) |
Total segment adjusted EBITDA |
| 105,115 |
|
| 129,023 |
| (19 | %) |
|
| 280,438 |
|
| 381,077 |
| (26 | %) |
Corporate |
| (33,369 | ) |
| (33,778 | ) | 1 | % |
|
| (96,174 | ) |
| (96,105 | ) | — | % |
Adjusted EBITDA | $ | 71,746 |
| $ | 95,245 |
| (25 | %) |
| $ | 184,264 |
| $ | 284,972 |
| (35 | %) |
Adjusted EBITDA excluding Contigo Health | $ | 72,606 |
| $ | 96,351 |
| (25 | %) |
| $ | 189,327 |
| $ | 290,146 |
| (35 | %) |
Adjusted net income | $ | 38,969 |
| $ | 54,926 |
| (29 | %) |
| $ | 98,009 |
| $ | 168,614 |
| (42 | %) |
Adjusted EPS | $ | 0.44 |
| $ | 0.49 |
| (10 | %) |
| $ | If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter. Related newsLast NewsRSA at Cybertech Europe 2024Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for… Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurityG11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes How Austria is making its AI ecosystem growAlways keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries Sparkle and Telsy test Quantum Key Distribution in practiceSuccessfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing… Most readAlibaba Group Announces March Quarter 2025 and Fiscal Year 2025 Results$BABA #alibaba--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba”, “Alibaba Group” or the “company”)… Workhuman Ignites Industry Momentum as the Undisputed Leader in Employee…#employeerecognition--In a bold validation of its innovative approach to culture-building through employee recognition, Workhuman®, the world’s leading… U.S. Data Center Construction Market Outlook Report 2025-2030 Featuring…The "U.S. Data Center Construction Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The… Fiserv to Present at Upcoming Investor ConferencesFiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology solutions, announced its participation in the following… G11 Media Networks |